Washington, D.C., April 20, 2020 – The Partnership for DSCSA Governance (PDG), an industry governance body to support interoperability as required by the Drug Supply Chain Security Act (DSCSA), has elected Scott Mooney, Stephen Coady and Timothy Ward to its Board of Directors.
PDG Board Chair, Max Peoples, welcomed the new members and looks forward to their support, “A broad range of experience on PDG’s board of directors is very important for PDG to meet its ambitious goals and deadlines. Scott, Tim and Stephen bring a wealth of experience and expertise that will help PDG advance its mission to effectively and efficiently implement the DSCSA. We thank them for their willingness to serve!”
Executive Director, Eric Marshall, added, “We are thrilled to be able leverage the deep expertise these three industry leaders bring to the table as we continue to advance toward a shared vision for implementation of the DSCSA’s 2023 requirement for interoperable drug tracing.”
Scott Mooney is an industry expert in wholesale drug distribution. As Vice President of Distribution Operations at McKesson Corporation, Scott leads a cross functional team working to implement the standards and system necessary for the DSCSA across the McKesson Pharmaceutical business unit while supporting the DSCSA implementation at McKesson’s other business units such as Specialty Health, Medical Surgical and Packaging.
Stephen Coady is an industry leader on drug serialization and traceability. Stephen also serves as Program Manager at Apotex Inc and has over 33 years of experience in IT, Operations, Supply Chain and Supply Chain. Steve has been involved in Serialization and Track and Trace since 2008 and is currently leading a global, enterprise level Implementation team focused on meeting current and emerging global serialization requirements including US, EU, China, Brazil and Saudi Arabia and others.
Timothy Ward is a seasoned executive with a wealth of experience in complex distribution systems. Timothy is also the President of Hercules Pharmaceuticals and has over 20 years of experience in the pharmaceutical industry. Timothy is skilled in BSA/AML compliance, economic sanctions, Export Administration Regulations (EAR), Drug Supply Chain Security Act (DSCSA), Controlled Substances Act (CSA), anti-corruption and anti-fraud.
Scott, Tim and Stephen join the existing board members: Max Peoples (affiliated with Uptown Pharmacy), Melva Chavoya (affiliated with Walgreens), Kevin Capatch (affiliated with Geisinger Health), Brian Lee (affiliated with affiliated with Bristol-Myers Squibb), Elizabeth Gallenagh (affiliated with Healthcare Distribution Alliance), David Mason (affiliated with Novartis), Michael Mazur (affiliated with Pfizer), Matthew Sample (affiliated with AmerisourceBergen), Matthew Price (affiliated with Medline Industries), Jonathan Williams (affiliated with Cleveland Clinic).
The Partnership for DSCSA Governance (PDG) is the independent, balanced, sector-neutral nonprofit industry governance body that supports the secure, electronic, interoperable tracing, and verification of prescription drugs in the U.S. supply chain, as required by DSCSA. PDG’s membership includes leading authorized manufacturers, repackagers, wholesalers, third party logistics providers, and dispensers (hospitals and retail and independent pharmacies), as well as leading industry trade associations and technical experts. Together, these members are working to establish a comprehensive vision for industry’s implementation of secure, electronics systems and processes for drug traceability in the U.S.
For questions, please contact Eric Marshall, Executive Director at Eric.Marshall@LeavittPartners.com.